BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18006321)

  • 21. Novel hybrid virtual screening protocol based on pharmacophore and molecular docking for discovery of GSK-3β inhibitors.
    Liu X; Yu J; Luo Y; Dong H
    Chem Biol Drug Des; 2023 Feb; 101(2):326-339. PubMed ID: 35762873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening and its validation in enzyme- and cell-based assay.
    Joshi P; Gupta M; Vishwakarma RA; Kumar A; Bharate SB
    Chem Biol Drug Des; 2017 Jun; 89(6):964-971. PubMed ID: 27896926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Description and assessment of a model for GSK-3beta database virtual screening.
    Ventimila N; Dupont PY; Laguerre M; Dessolin J
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):152-7. PubMed ID: 20170337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays.
    Lin CH; Hsieh YS; Wu YR; Hsu CJ; Chen HC; Huang WH; Chang KH; Hsieh-Li HM; Su MT; Sun YC; Lee GC; Lee-Chen GJ
    Eur J Pharm Sci; 2016 Jun; 89():11-9. PubMed ID: 27094783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of potential glycogen synthase kinase 3 inhibitors using pharmacophore mapping and virtual screening.
    Dessalew N; Bharatam PV
    Chem Biol Drug Des; 2006 Sep; 68(3):154-65. PubMed ID: 17062013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative Structure-Activity Relationship Analysis and a Combined Ligand-Based/Structure-Based Virtual Screening Study for Glycogen Synthase Kinase-3.
    Fu G; Liu S; Nan X; Dale OR; Zhao Z; Chen Y; Wilkins DE; Manly SP; Cutler SJ; Doerksen RJ
    Mol Inform; 2014 Sep; 33(9):627-40. PubMed ID: 27486081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability.
    Saitoh M; Kunitomo J; Kimura E; Iwashita H; Uno Y; Onishi T; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GP; Snell GP; Takizawa M; Itoh F; Kori M
    J Med Chem; 2009 Oct; 52(20):6270-86. PubMed ID: 19775160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure based de novo design of novel glycogen synthase kinase 3 inhibitors.
    Dessalew N; Bharatam PV
    Bioorg Med Chem; 2007 Jun; 15(11):3728-36. PubMed ID: 17399989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-Silico Screening of Ligand Based Pharmacophore, Database Mining and Molecular Docking on 2, 5-Diaminopyrimidines Azapurines as Potential Inhibitors of Glycogen Synthase Kinase-3β.
    Mishra P; Kesar S; Paliwal SK; Chauhan M; Madan K
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):150-158. PubMed ID: 29848281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
    Furlotti G; Alisi MA; Cazzolla N; Dragone P; Durando L; Magarò G; Mancini F; Mangano G; Ombrato R; Vitiello M; Armirotti A; Capurro V; Lanfranco M; Ottonello G; Summa M; Reggiani A
    J Med Chem; 2015 Nov; 58(22):8920-37. PubMed ID: 26486317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.
    Bidon-Chanal A; Fuertes A; Alonso D; Pérez DI; Martínez A; Luque FJ; Medina M
    Eur J Med Chem; 2013 Feb; 60():479-89. PubMed ID: 23354070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An ESI-MS/MS method for screening of small-molecule mixtures against glycogen synthase kinase-3beta (GSK-3beta).
    Partserniak I; Werstuck G; Capretta A; Brennan JD
    Chembiochem; 2008 May; 9(7):1065-73. PubMed ID: 18348127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological evaluation and energetic analyses of novel GSK-3β inhibitors.
    Zhang D; Liu L; Pang L; Jin Q; Ke K; Hu M; Yang J; Ma W; Xie H; Chen X
    J Cell Biochem; 2018 Apr; 119(4):3510-3518. PubMed ID: 29144001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening.
    Dessalew N; Bharatam PV
    Biophys Chem; 2007 Jul; 128(2-3):165-75. PubMed ID: 17482749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and evaluation of 7-azaindazolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors.
    Ye Q; Shen Y; Zhou Y; Lv D; Gao J; Li J; Hu Y
    Eur J Med Chem; 2013 Oct; 68():361-71. PubMed ID: 23994329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
    Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
    J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
    Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
    J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinolone derivatives containing strained spirocycle as orally active glycogen synthase kinase 3β (GSK-3β) inhibitors for type 2 diabetics.
    Seto S; Yumoto K; Okada K; Asahina Y; Iwane A; Iwago M; Terasawa R; Shreder KR; Murakami K; Kohno Y
    Bioorg Med Chem; 2012 Feb; 20(3):1188-200. PubMed ID: 22261023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3.
    Zhang HC; Boñaga LV; Ye H; Derian CK; Damiano BP; Maryanoff BE
    Bioorg Med Chem Lett; 2007 May; 17(10):2863-8. PubMed ID: 17350261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching.
    Conde S; Pérez DI; Martínez A; Perez C; Moreno FJ
    J Med Chem; 2003 Oct; 46(22):4631-3. PubMed ID: 14561081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.